@article{ref1,
title="Chemotherapy-induced peripheral neuropathy: association with increased risk of falls and injuries",
journal="Clinical journal of oncology nursing",
year="2019",
author="Autissier, Estelle",
volume="23",
number="4",
pages="405-410",
abstract="BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and degenerative side effect of many commonly used chemotherapy agents. Symptoms manifest as sensory and motor neuropathies. CIPN may necessitate chemotherapy dose reduction or discontinuation. <br><br>OBJECTIVES: This review intends to summarize literature linking CIPN to an increased risk of falls and injuries and provides recommendations to help maintain patient safety and maximize physical function. <br><br>METHODS: A literature search was conducted using MEDLINE®, PubMed®, and ScienceDirect. <br><br>FINDINGS: Assessment of CIPN and CIPN-related falls and injuries is vital in preventing related complications, and proper education of oncology nursing staff on CIPN assessment and management is necessary.<p /> <p>Language: en</p>",
language="en",
issn="1092-1095",
doi="10.1188/19.CJON.405-410",
url="http://dx.doi.org/10.1188/19.CJON.405-410"
}